<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04856514</url>
  </required_header>
  <id_info>
    <org_study_id>21-039-UWM-a</org_study_id>
    <nct_id>NCT04856514</nct_id>
  </id_info>
  <brief_title>Open Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1</brief_title>
  <official_title>Effectiveness of a Telehealth Group for Improving Peer Relationships for Adolescents With Neurofibromatosis Type 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Milwaukee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NF Midwest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Milwaukee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open trial of the UCLA PEERS protocol delivered via Telehealth with teens with&#xD;
      neurofibromatosis type 1 whose parents report that they have difficulty making and keeping&#xD;
      friends.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 5, 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Social Skills Improvement System - SEL (SSIS-SEL; Gresham &amp; Elliot, 2017)</measure>
    <time_frame>within four weeks of PEERS completion</time_frame>
    <description>Parental report of social skills (SSIS-SEL Total Score; Mean 100, SD 15; Higher scores mean stronger social functioning</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Test of Adolescent Social SKills (TASSK: Laugeson &amp; Frankel, 2010)</measure>
    <time_frame>within four weeks of PEERS completion</time_frame>
    <description>Questionnaire completed by teen participants; measures knowledge of the PEERS intervention concepts (raw total score; higher score means stronger functioning)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Social Responsiveness Scale (SRS; Constantino, 2005)</measure>
    <time_frame>within four weeks of PEERS completion</time_frame>
    <description>Questionnaire completed by caregivers on social function and autism symptoms (SRS Total Score; Mean 50, SD 10; higher scores mean greater difficulties</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Neurofibromatosis 1</condition>
  <condition>Social Skills</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participation in 16 week telehealth administration of the PEERS protocol for teens (parallel teen and parent/caregiver groups)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PEERS</intervention_name>
    <description>16 week telehealth intervention; parallel teen and parent/caregiver groups; 90 minutes each week.</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Physician diagnosis of neurofibromatosis type 1&#xD;
&#xD;
          -  Age 12-17&#xD;
&#xD;
          -  Main language spoken in the home is English&#xD;
&#xD;
          -  Reliable internet access&#xD;
&#xD;
          -  Current functional impairment in peer relationships&#xD;
&#xD;
          -  Teen is interested and motivated to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Main language spoken in the home is not English&#xD;
&#xD;
          -  Cognitive or developmental delays that affect reading comprehension or understanding&#xD;
             of treatment material&#xD;
&#xD;
          -  Significant behavioral concerns&#xD;
&#xD;
          -  Other comorbid medical conditions&#xD;
&#xD;
          -  Major surgery in past 6 months&#xD;
&#xD;
          -  Prior social skills group treatment within past 6 months&#xD;
&#xD;
          -  Prior participation in PEERS&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danielle Glad, M.S.</last_name>
    <role>Study Director</role>
    <affiliation>University of Wisconsin, Milwaukee</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin-Milwaukee</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 19, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Wisconsin, Milwaukee</investigator_affiliation>
    <investigator_full_name>Bonita P Klein-Tasman</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurofibromatoses</mesh_term>
    <mesh_term>Neurofibromatosis 1</mesh_term>
    <mesh_term>Neurofibroma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data will be available upon request to qualitied investigators.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Available following publication of the research findings</ipd_time_frame>
    <ipd_access_criteria>Contact the PI (bklein@uwm.edu)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

